KINTOR PHARMACEUTICAL LIMITED

Insiders Kintor Pharmaceutical Limited

Equities

9939

KYG5273B1077

Delayed Hong Kong S.E. Other stock markets 03:55:33 14/05/2024 BST			5-day change	1st Jan Change
1.15 ^HKD	+4.55%		0.00%	-32.52%

04-22	Kintor Pharmaceutical Limited Announces Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China Reaches Primary Endpoint	CI
04-22	Kintor Pharmaceutical Concludes Phase II Clinical Trial for Androgenic Alopecia Treatment	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kintor Pharmaceutical Limited Appoints Ming Ming Cheung as Joint Company Secretary	12/05/23	CI
Kintor Pharmaceutical Limited Announces Management Changes	14/04/23	CI
Kintor Pharmaceutical Limited Announces Board Changes	05/05/22	CI
Kintor Pharmaceutical Limited Announces Executive Changes	18/02/22	CI
Kintor Pharmaceutical Limited Announces Change of Directors	03/02/22	CI
Kintor Pharmaceutical Limited Announces Management Changes	26/11/21	CI
Kintor Pharmaceutical Limited Announces Board Changes	27/09/21	CI
Kintor Pharmaceutical Limited Announces Board Changes	22/06/21	CI
Kintor Pharmaceutical Limited Appoints Qun Lu as Chief Technology Officer	16/05/21	CI
Kintor Pharmaceutical Limited Announces Executive Changes	30/04/21	CI
Kintor Pharmaceutical Limited Announces Board and Committee Changes	29/12/20	CI
Kintor Pharmaceutical Limited Announces Directors Appointments	27/10/20	CI
Kintor Pharmaceutical Limited Announces Board Changes	17/07/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer